Saba Capital trims ECAT stake in January 2026 sales
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two January 2026 transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two January 2026 transactions. On January 13, 2026, it sold 11,153 shares at a price of $15.92 per share, leaving 26,302,501 shares beneficially owned indirectly after that trade. On January 14, 2026, it sold a further 75,713 shares at $15.89 per share, bringing its indirect beneficial ownership to 26,226,788 ECAT shares following the second transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 75,713 | $15.89 | $1.20M |
| Sale | Common Stock | 11,153 | $15.92 | $178K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Saba Capital Management report in this Form 4 for ECAT?
Is Saba Capital Management a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT)?
Are Saba Capital Management’s ECAT holdings reported as direct or indirect ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.